Please assess the completion status of the following clinical trial:

Trial Title: Home Hospital for Lymphoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 or older~* Receiving their lymphoma care with curative intent at MGH (treatment intent based upon chemotherapy order in the electronic medical record)~* Hemodynamically stable during the first 24 hours of hospital admission at MGH~* Residing within the designated geographic area for MGH Home Hospital Service (an approximately 10-mile radius from MGH)~* Able to communicate and respond to questionnaires in English~* Lives with a family member or a friend who supports the patient at home~* Deemed eligible for supportive oncology care at home based on the MGH Home Hospital clinician evaluation~Exclusion Criteria:~* Those admitted to the intensive care unit~* Have high oxygen requirement (FIO2 \> 0.4)~* Experience active angina or cardiac arrythmias~* Have a planned inpatient surgical or interventional procedure~* Have uncontrolled psychiatric illness or impaired cognition that prohibits complying with the study procedures~* Have uncontrolled pain requiring intravenous pain medications~* Those deemed ineligible based on the Home Hospital Service clinician evaluation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Home Hospital for Lymphoma (Type: EXPERIMENTAL): The Home Hospital for Lymphoma intervention entails the following: patient-reported symptoms and vital signs with appropriate triggers for phone calls and home visits, and regular communication with oncology clinicians regarding care delivered at home to ensure continuity of care.

Based on this trial design, predict the completion outcome and termination type (if applicable).